CSF2 and neoplasm: In clinical immunotherapies and the regulation of the anti-tumor immune response, monocytes are isolated from patient peripheral blood mononuclear cells (PBMCs) and differentiated into DCs through incubation with granulocyte-macrophage colony-stimulating factor (GM-CSF) and other cytokines for about 5 days.